{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:49:03Z","timestamp":1790470143906,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.beem.2021.101496","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T12:27:02Z","timestamp":1613392022000},"page":"101496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hypercoagulability in Cushing\u2019s syndrome: From arterial to venous disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Matthieu","family":"St-Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn S.T.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9996","key":"10.1016\/j.beem.2021.101496_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"Xx","key":"10.1016\/j.beem.2021.101496_bib3","first-page":"1","article-title":"Epidemiology and comorbidity of adrenal cushing\u2019s syndrome: a nationwide cohort study","volume":"XX","author":"Ahn","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing\u2019s syndrome: results from the ERCUSYN Registry","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF03345431","article-title":"Advances in the epidemiology, pathogenesis, and management of Cushing\u2019s syndrome complications","volume":"35","author":"Arnaldi","year":"2012","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib7","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib8","article-title":"Hypercoagulability in cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study","volume":"4","author":"Suarez","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib10","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of cushing\u2019s syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib13","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with cushing\u2019s disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jc.2011-3123","article-title":"Body composition and cardiovascular risk markers after remission of Cushing\u2019s Disease: a prospective study using whole-body MRI","volume":"97","author":"Geer","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib15","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2021.101496_bib18","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with cushing\u2019s syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101496_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.wneu.2019.10.077","article-title":"Cerebral venous sinus thrombosis after transsphenoidal resection: a rare complication of cushing disease\u2013associated hypercoagulability","volume":"134","author":"Soni","year":"2020","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101496_bib21","series-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing\u2019s syndrome: a systematic meta-analysis","first-page":"9","author":"Wagner","year":"2019"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib22","first-page":"3662","volume":"87","author":"Boscaro","year":"2002","journal-title":"Thromboembolic Complications in Cushing \u2019 s Syndrome"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","article-title":"Long-term follow-up results of transsphenoidal surgery for Cushing\u2019s disease in a single centre using strict criteria for remission","volume":"56","author":"Rees","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12020-015-0665-z","article-title":"A\u00a0venous thromboembolism risk assessment model for patients with Cushing\u2019s syndrome","volume":"52","author":"Zilio","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib25","first-page":"310","article-title":"Complications in a contemporary series of patients who underwent transsphenoidal surgery for Gushing\u2019s disease","volume":"9","author":"Semple","year":"1999","journal-title":"Skull Base Surg"},{"issue":"10","key":"10.1016\/j.beem.2021.101496_bib26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1507\/endocrj.EJ14-0102","article-title":"D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing\u2019s syndrome","volume":"61","author":"Fukuoka","year":"2014","journal-title":"Endocr J"},{"issue":"10","key":"10.1016\/j.beem.2021.101496_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0033-1355385","article-title":"Disorders of hemostasis in overt and subclinical hypercortisolism","volume":"121","author":"\u015awiatkowska-Stodulska","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib28","doi-asserted-by":"crossref","first-page":"M11","DOI":"10.1530\/EJE-15-0198","article-title":"Adverse effects of glucocorticoids: Coagulopathy","volume":"173","author":"Coelho","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing\u2019s syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"Van Der Pas","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","article-title":"Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing\u2019s syndrome: results from a prospective study before and after surgery","volume":"163","author":"Manetti","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03343697","article-title":"Markers of activation of coagulation and fibrinolysis in patients with Cushing\u2019s syndrome","volume":"23","author":"Fatti","year":"2000","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03345709","article-title":"Blood coagulation and fibrinolysis in patients with Cushing\u2019s syndrome: increased plasminogen activator inhibitor-I, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels","volume":"32","author":"Erem","year":"2009","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/jc.2011-2753","article-title":"The hypercoagulable state in cushing\u2019s disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy","volume":"97","author":"van der Pas","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101496_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-013-0467-3","article-title":"Thrombin generation in Cushing\u2019s Syndrome: do the conventional clotting indices tell the whole truth?","volume":"17","author":"Koutroumpi","year":"2014","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib35","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing\u2019s syndrome: a systematic review","volume":"94","author":"Van Zaane","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00001721-199212000-00013","article-title":"AG. The fibrinolytic potential in patiens with Cushing\u2019s disease: a clue to their hypercoagulable state","volume":"3","author":"Patrassi","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/cen.12491","article-title":"Rotation thromboelastometry and the hypercoagulable state in Cushing\u2019s syndrome","volume":"81","author":"Alves Coelho","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2021.101496_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","article-title":"Hypercoagulability in Cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers","volume":"36","author":"Kastelan","year":"2009","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2021.101496_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2265.2012.04479.x","article-title":"Hypercoagulable state in Cushing\u2019s syndrome is reversible following remission","volume":"78","author":"Kastelan","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2021.101496_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.0954-6820.1985.tb03254.x","article-title":"Haemostatic parameters in cushing\u2019s syndrome","volume":"217","author":"Ikkala","year":"1985","journal-title":"Acta Med Scand"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001721-199904000-00006","article-title":"Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing??s syndrome","volume":"10","author":"Casonato","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"8943","key":"10.1016\/j.beem.2021.101496_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib43","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-15-0308","article-title":"Mechanisms IN endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect","volume":"173","author":"Isidori","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11102-012-0398-4","article-title":"Venous thromboembolism in patients with Cushing\u2019s syndrome: need of a careful investigation of the prothrombotic risk profile","volume":"16","author":"Koutroumpi","year":"2013","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib45","first-page":"3662","article-title":"Anticoagulant prophylaxis markedly reduces thromboembolic complications in cushing\u2019s syndrome","volume":"87","author":"Boscaro","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MBC.0b013e3283548dfc","article-title":"Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism","volume":"23","author":"Chopra","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000323765","article-title":"New insight into the hypercoagulability of Cushing\u2019s syndrome","volume":"93","author":"Daidone","year":"2011","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1530\/EJE-11-0535","article-title":"The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing\u2019s syndrome","volume":"165","author":"swiatkowska-Stodulska","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1507\/endocrj.EJ14-0539","article-title":"Activity of selected coagulation factors in overt and subclinical hypercortisolism","volume":"62","author":"\u015awi\u0105tkowska-Stodulska","year":"2015","journal-title":"Endocr J"},{"issue":"11","key":"10.1016\/j.beem.2021.101496_bib50","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanov\u00e0","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cen.13521","article-title":"Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission","volume":"88","author":"Aranda","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cen.12524","article-title":"Enhanced oxidative stress and platelet activation in patients with Cushing\u2019s syndrome","volume":"82","author":"Karamouzis","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib53","first-page":"207","article-title":"Assessment of platelet function in endogenous hypercortisolism","volume":"66","author":"Swiatkowska-Stodulska","year":"2015","journal-title":"Endokrynol Pol"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12020-007-0033-8","article-title":"Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing\u2019s Syndrome","volume":"31","author":"Baykan","year":"2007","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1507\/endocrj.K09E-260","article-title":"Endothelial dysfunction associated with hypercortisolism is reversible in cushing\u2019s syndrome","volume":"57","author":"Akaza","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2021.101496_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570161043476483","article-title":"Glucocorticoids and vascular reactivity","volume":"2","author":"Yang","year":"2004","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1530\/eje.0.1490549","article-title":"Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing\u2019s syndrome","volume":"149","author":"Kirilov","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101496_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103940","article-title":"New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing\u2019s syndrome: a pilot noninvasive study by transthoracic Doppler echocardiography","volume":"128","author":"Tona","year":"2020","journal-title":"Microvasc Res"},{"key":"10.1016\/j.beem.2021.101496_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109695","article-title":"Mineralocorticoid receptor excessive activation involved in glucocorticoid-related brain injury","volume":"122","author":"Chen","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib60","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.hjh.0000226182.60321.69","article-title":"Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review","volume":"24","author":"Duprez","year":"2006","journal-title":"J\u00a0Hypertens"},{"issue":"7","key":"10.1016\/j.beem.2021.101496_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17070797","article-title":"Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension","volume":"17","author":"Mu\u00f1oz-Durango","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2021.101496_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vph.2016.04.005","article-title":"A\u00a0novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification","volume":"86","author":"Zhu","year":"2016","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.beem.2021.101496_bib63","series-title":"Mortality and morbidity in Cushing\u2019s syndrome in New Zealand","first-page":"436","author":"Bolland","year":"2011"},{"issue":"11","key":"10.1016\/j.beem.2021.101496_bib64","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib65","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1210\/js.2018-00278","article-title":"Is VTE prophylaxis necessary on discharge for patients undergoing adrenalectomy for cushing syndrome?","volume":"3","author":"Babic","year":"2019","journal-title":"J\u00a0Endocr Soc."},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib66","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.emc.2017.06.003","article-title":"Deep venous thrombosis","volume":"35","author":"Olaf","year":"2017","journal-title":"Emerg Med Clin"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib67","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cen.12299","article-title":"Diagnosis and complications of Cushing\u2019s disease: gender-related differences","volume":"80","author":"Zilio","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib68","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/EJE-19-0877","article-title":"Management OF endocrine disease: cushing\u2019s syndrome due to ectopic ACTH secretion: an expert operational opinion","volume":"182","author":"Young","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib69","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib70","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","article-title":"High variability in baseline urinary free cortisol values in patients with Cushing\u2019s disease","volume":"80","author":"Petersenn","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib71","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12020-016-0914-9","article-title":"The degree of urinary hypercortisolism is not correlated with the severity of cushing\u2019s syndrome","volume":"55","author":"Guarnotta","year":"2017","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib72","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0036-1592333","article-title":"Environmental and genetic risk factors associated with venous thromboembolism","volume":"42","author":"Crous-Bou","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"10.1016\/j.beem.2021.101496_bib73","first-page":"632","article-title":"Anesthesia in patients with neuromuscular disorders","volume":"75","author":"Schmitt","year":"2009","journal-title":"Minerva Anestesiol"},{"issue":"9","key":"10.1016\/j.beem.2021.101496_bib74","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.beem.2021.101496_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/asheducation-2016.1.180","article-title":"Thrombosis in the setting of obesity or inflammatory bowel disease","volume":"2016","author":"Lentz","year":"2016","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.beem.2021.101496_bib76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-15-0968","article-title":"Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors","volume":"174","author":"Kamp","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2021.101496_bib77","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1530\/EC-20-0299","article-title":"Venous thromboembolism in patients with adrenocortical carcinoma after surgery","volume":"9","author":"Durmu\u015fo\u011flu","year":"2020","journal-title":"Endocr Connect"},{"issue":"10","key":"10.1016\/j.beem.2021.101496_bib78","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Outcome of bilateral adrenalectomy in cushing\u2019s syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib79","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.surg.2018.05.028","article-title":"Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: systematic review and meta-analysis of randomized clinical trials","volume":"164","author":"Rausa","year":"2018","journal-title":"Surgery"},{"issue":"2 SUPPL.","key":"10.1016\/j.beem.2021.101496_bib80","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib81","doi-asserted-by":"crossref","DOI":"10.3171\/2014.10.FOCUS14705","article-title":"Complications after transsphenoidal surgery for patients with Cushing\u2019s disease and silent corticotroph adenomas","volume":"38","author":"Smith","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"2\u20133","key":"10.1016\/j.beem.2021.101496_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.disamonth.2005.02.003","article-title":"Thrombosis risk assessment as a guide to quality patient care","volume":"51","author":"Caprini","year":"2005","journal-title":"Disease-a-Month"},{"key":"10.1016\/j.beem.2021.101496_bib83","first-page":"345","article-title":"Can the Caprini score predict thromboembolism and guide pharmacologic prophylaxis after primary joint arthroplasty?","volume":"21","author":"Gold","year":"2020","journal-title":"J\u00a0Orthop"},{"key":"10.1016\/j.beem.2021.101496_bib84","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-20-1309","article-title":"Cardiovascular risk assessment, thromboembolism and infection prevention in Cushing\u2019s syndrome \u2013 a practical approach","author":"Varlamov","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101496_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4928","article-title":"Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing\u2019s syndrome: cohort study","volume":"345","author":"Fardet","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib86","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12020-015-0608-8","article-title":"Peptic ulcer disease in endogenous hypercortisolism: myth or reality?","volume":"50","author":"Hatipoglu","year":"2015","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2021.101496_bib87","first-page":"348","article-title":"Aspirin in the primary prophylaxis of venous thromboembolism in surgical patients","volume":"13","author":"Sahebally","year":"2015","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib88","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","article-title":"Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis","volume":"4","author":"Kunutsor","year":"2017","journal-title":"Lancet Haematol"},{"issue":"23","key":"10.1016\/j.beem.2021.101496_bib89","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.beem.2021.101496_bib90","article-title":"Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery","volume":"8","author":"Felder","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib91","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11102-014-0600-y","article-title":"Perioperative thromboprophylaxis in Cushing\u2019s disease: what we did and what we are doing?","volume":"18","author":"Barbot","year":"2015","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2021.101496_bib92","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12020-018-1669-2","article-title":"Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing\u2019s disease","volume":"62","author":"Barbot","year":"2018","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2021.101496_bib93","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-17-0997","article-title":"Preoperative medical treatment in Cushing\u2019s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN","volume":"178","author":"Valassi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101496_bib94","series-title":"Cochrane database of systematic reviews","article-title":"Elastic compression stockings for prevention of deep vein thrombosis","author":"Sachdeva","year":"2010"},{"issue":"21","key":"10.1016\/j.beem.2021.101496_bib95","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.beem.2021.101496_bib96","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","article-title":"Aspirin for the prevention of recurrent venous thromboembolism","volume":"130","author":"Simes","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.beem.2021.101496_bib97","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis After total hip arthroplasty","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.beem.2021.101496_bib98","first-page":"49","article-title":"Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study","volume":"18","author":"Imberti","year":"2020","journal-title":"Blood Transfus"},{"issue":"2","key":"10.1016\/j.beem.2021.101496_bib100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:57:19Z","timestamp":1761497839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1521690X21000130"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101496","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercoagulability in Cushing\u2019s syndrome: From arterial to venous disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101496"}}